Troubles that made Idec drop its lead drug convinced it to take on manufacturing. From a stock price in June 1994 of $2.44 to a stock price of $24 in September 1996, whatever becomes of the products now coming through Idec's pipeline, the strategy that got it out of some bad times is worth a closer look.
by Deborah Erickson
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights